Alzheimer's: Proteomics gives clues toward alternatives to amyloid

(Emory Health Sciences) In Alzheimer's research, one particular protein looms large: plaque-forming amyloid-beta. Yet plaques can accumulate decades before symptoms appear, and clinical trials aimed at controlling amyloid-beta have mostly flopped so far. Emory scientists are using proteomics to look for alternative mechanisms and treatment strategies.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2hAbrNu